Abstract: An optical relay comprises a first scan mirror configured to receive an input optical beam, and to reflect the input optical beam as a first intermediate optical beam; a telecentric mirror configured to receive the first intermediate optical beam, and to reflect the first intermediate optical beam as a second intermediate optical beam; a second scan mirror configured to receive the second intermediate optical beam, and to reflect the second intermediate optical beam as an output optical beam; and a lens system disposed between the telecentric mirror and the first and second scan mirrors, such that the first intermediate optical beam and the second intermediate optical beam pass through the lens system. The optical relay may be a component of an optical system which further includes an optical engine.
Abstract: In one aspect, the invention relates to chemical modulators of insect olfactory receptors. In particular, compounds and compositions are provided that can inhibit sensory (e.g., host targeting) functions in airborne insects such as mosquitos. Methods of employing such agents, and articles incorporating the same, are also provided. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Type:
Grant
Filed:
July 31, 2020
Date of Patent:
November 1, 2022
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Laurence Zwiebel, Gregory M. Pask, David C. Rinker, Ian M. Romaine, Gary A. Sulikowski, Paul R. Reid, Alex G. Waterson, Kwangho Kim, Patrick L. Jones, Robert W. Taylor
Abstract: Thromboxane A2 receptor antagonists, such as ifetroban, inhibit solid tumor metastasis. The formation of surface and microscopic lung metastases are inhibited. Thromboxane A2 receptor antagonists can inhibit the tumor metastasis process without affecting the growth or development of a primary tumor.
Abstract: A robot for transporting a biodevice from one place to another place, comprising a body for carrying the biodevice; a driving assembly for driving the body in omnidirectional motion; a sensing unit for sensing at least a position and orientation of the body; and a control unit coupled to the driving assembly and the sensing unit for generating one or more control signals based on at least the sensed position and orientation of the body to drive the driving assembly so as to move the body to a desired place and to arrive with the correct orientation.
Abstract: The present disclosure provides for a device and method of control for an artificial prosthetic knee. A prosthetic knee according to the present disclosure relies on strictly passive means of providing support during weight bearing and supplements a resistive swing-phase mechanism with a small powered actuator. This actuator adds power to the knee, exclusively during swing phase, to improve swing-phase behavior. In particular, the knee still relies on the resistive swing-phase mechanism to provide nominal swing-phase knee motion, but supplements that motion as needed with the small powered actuator.
Type:
Grant
Filed:
January 25, 2019
Date of Patent:
October 18, 2022
Assignee:
Vanderbilt University
Inventors:
Michael Goldfarb, Almaskhan Baimyshev, Harrison Bartlett, Jantzen Lee
Abstract: In one aspect of the invention, the fluidic device includes a fluidic chip includes a body having a first surface and an opposite, second surface, one or more channels formed in the body in fluidic communications with input ports and output ports for transferring one or more fluids between the input ports and the output ports, and a fluidic chip registration means formed on the first surface for aligning the fluidic chip with a support structure; and an actuator configured to engage with the one or more channels at the second surface of the body for selectively and individually transferring the one or more fluids through the one or more channels from at least one of the input ports to at least one of the output ports at desired flowrates.
Type:
Grant
Filed:
August 20, 2019
Date of Patent:
October 11, 2022
Assignee:
VANDERBILT UNIVERSITY
Inventors:
David K. Schaffer, Dmitry A. Markov, Ronald S. Reiserer, Lisa McCawley, Michael Geuy, Clayton M. Britt, John P. Wikswo
Abstract: A method of fabricating a carbon nanotube (“CNT”) array includes providing a substrate with a CNT catalyst disposed on a surface of the substrate, heating the CNT catalyst to an annealing temperature, exposing the CNT catalyst to a CNT precursor for an exposure period to pre-load the CNT catalyst, and exposing the pre-loaded CNT catalyst to a carbon source for a growth period to form the CNT array. The formed CNT array comprises a plurality of CNT bundles that are aligned with one another in an alignment direction. At least one of the plurality of bundles comprises an average structural factor of 1.5 or less along an entirety of the length thereof.
Type:
Application
Filed:
March 31, 2021
Publication date:
October 6, 2022
Applicants:
Toyota Motor Engineering & Manufacturing North America, Inc., Vanderbilt University
Inventors:
Yuyang Song, Shailesh N. Joshi, Piran R. Kidambi, Peifu Cheng
Abstract: The invention includes 2-?-naphthyl-acetic acid derivatives, which are selective AKR1C3 inhibitors. In certain embodiments, the compounds of the invention are (R)-naproxen analogs. The invention further includes methods of treating cancer, such as prostate cancer and/or castration-resistant prostate cancer, using at least one compound of the invention.
Type:
Grant
Filed:
October 21, 2016
Date of Patent:
October 4, 2022
Assignees:
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, VANDERBILT UNIVERSITY
Inventors:
Trevor M. Penning, Adegoke Adeniji, Lawrence J. Marnett
Abstract: The present disclosure is directed to human monoclonal IgE antibodies, and IgG antibodies engineered therefrom. Such engineered antibodies can be used to blunt pathologic IgE responses in subjects, such as in the treatment or prevention of allergies.
Abstract: Devices, kits, and methods for testing the integrity of a cavity within an anatomical organ. For example, the devices, kits, and methods described herein are useful for detecting leaks in an anastomosis or for testing the integrity or repair of a defect in anatomy.
Abstract: A continuous automated perfusion culture analysis system (CAPCAS) comprises one or more fluidic systems configured to operate large numbers of biodevices in parallel. Each fluidic system comprises an input reservoir plate for receiving media; a biodevice plate comprising an array of biodevices fluidically coupled to the input reservoir plate, configured such that each biodevice has independent media delivery, fluid removal, stirring, and gas control, and each biodevice is capable of continuously receiving the media from the input reservoir plate; and an output plate fluidically coupled to the biodevice plate for real-time analysis and sampling. The operations of the CAPCAS are automated and computer-controlled wirelessly. The CAPCAS can also be used for abiotic and biotic chemical synthesis processes.
Type:
Grant
Filed:
January 19, 2022
Date of Patent:
September 20, 2022
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Ronald S. Reiserer, Gregory B. Gerken, David K. Schaffer, John P. Wikswo
Abstract: Provided are apparatuses for augmenting human speed, human-driven compliant mechanisms, artificial limbs to augment human movement, and the like. The apparatuses can include variable stiffness mechanisms including springs that can be configured to selectively store and subsequently release energy generated by human movement. The apparatuses can selectively release the captured energy supplied by the human to provide force and power output beyond the physical capability of the human.
Type:
Grant
Filed:
December 18, 2020
Date of Patent:
September 13, 2022
Assignee:
VANDERBILT UNIVERSITY
Inventors:
David Braun, Amanda Sutrisno, Tiange Zhang
Abstract: The present disclosure is directed to antibodies binding to and neutralizing the coronavirus designated SARS-CoV-2 and methods for use thereof.
Type:
Application
Filed:
March 18, 2022
Publication date:
September 8, 2022
Applicant:
Vanderbilt University
Inventors:
James E. CROWE, JR., Seth ZOST, Robert CARNAHAN, Pavlo GILCHUK
Abstract: Systems and methods are provided for testing a threshold energy required to cause a latchup on an electronic component. An exemplary method includes applying a series of laser pulses to a testing object with a pulsed laser unit. The testing object is connected to a testing circuit which can measure the energy of each of the series of laser pulses, and detect whether a pulse of the series of laser pulses resulted in a latchup on the testing object. Upon detecting the pulse, the method provides for logging the energy of the pulse using a recording unit and logging the latchup status of the test device. If a latchup is detected, the testing circuit automatically mitigates the latchup event.
Type:
Grant
Filed:
February 8, 2018
Date of Patent:
September 6, 2022
Assignee:
Vanderbilt University
Inventors:
Andrew L. Sternberg, Ronald D. Schrimpf, Robert A. Reed
Abstract: A steerable surgical needle (10) includes an elongated needle shaft (12), a beveled tip portion (14), and a flexural element (16) that connects the needle shaft (12) with the tip portion (14) and permits the tip portion to deflect relative to the needle shaft. A method for steering the surgical needle (10) through tissue includes the steps of advancing the needle in the body tissue to induce tip flexure which causes the needle to follow a curved trajectory, and rotating the needle about its longitudinal axis in place, without advancement, to remove the tip flexure.
Type:
Grant
Filed:
October 30, 2019
Date of Patent:
August 30, 2022
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Philip J. Swaney, Robert J. Webster, III
Abstract: Indazole compounds which are useful as allosteric potentiators/positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds, for example, in treating neurological and psychiatric disorders or other disease states associated with glutamate dysfunction.
Type:
Grant
Filed:
August 16, 2018
Date of Patent:
August 30, 2022
Assignee:
Vanderbilt University
Inventors:
P. Jeffrey Conn, Craig W. Lindsley, Andrew S. Felts, Colleen M. Niswender, Rory A. Capstick, Paul K. Spearing, Sean R. Bollinger
Abstract: Disclosed herein are 3-azabicyclo[3.1.0]hexan-6-amine compounds, which may be useful as antagonists of the muscarinic acetylcholine receptor M4 (mAChR M4). Also disclosed herein are methods of making the compounds, pharmaceutical compositions comprising the compounds, and methods of treating disorders using the compounds and compositions.
Type:
Grant
Filed:
February 1, 2019
Date of Patent:
August 16, 2022
Assignee:
Vanderbilt University
Inventors:
Craig W. Lindsley, P. Jeffrey Conn, Darren W. Engers, Julie L. Engers, Aaron M. Bender
Abstract: A method for using information of patient-specific cochlea size and/or shape to determine a patient-customized cochlear implant electrode insertion and placement plan includes segmenting shapes of structures of interest (SOIs) of the cochlea in a pre-operative CT image of the cochlea using a shape model; defining a 3D modiolar hugging curve within the shape model of the SOIs as a sequence of points; automatically transforming the defined 3D modiolar hugging curve to the pre-operative CT image so as to obtain a modiolar curve in the cochlea; rigidly registering an EA shape model of the EA to the modiolar curve in the cochlea, thereby placing a resting state shape of the EA within the patient's SOIs such that the EA matches the modiolar curve in the cochlea; and determining a patient-customized insertion plan for electrode placement using the registered EA shape model.
Type:
Grant
Filed:
April 24, 2018
Date of Patent:
August 9, 2022
Assignee:
VANDERBILT UNIVERSITY
Inventors:
Jack H. Noble, Robert F. Labadie, Benoit M. Dawant
Abstract: Metallic and dielectric domains in phase change materials (PCM) provide spatially localized changes in the local dielectric environment, enabling launching, reflection, and transmission of hyperbolic polaritons (HPs) at the PCM domain boundaries, and tuning the wavelength of HPs propagating in hyperbolic materials over these domains, providing a methodology for realizing planar, sub-diffractive refractive optics. This approach offers reconfigurable control of in-plane HP propagation to provide design optical functionality because the phase change material can be manipulated by changing the local structure, for example, to manipulate polaritons in the adjacent hyperbolic material, thus tuning the wave propagation properties of the polaritons in the hyperbolic material.
Type:
Grant
Filed:
March 7, 2019
Date of Patent:
August 9, 2022
Assignees:
Vanderbilt University, University of Georgia Research Foundation, Inc.
Inventors:
Joshua D. Caldwell, Thomas G. Folland, Richard F. Haglund, Yohannes Abate
Abstract: Devices and methods for visibly highlighting areas of a region including an imager configured to image the region with a sensitivity to at least one of wavelength, light level, or contrast greater than the human eye, an overlay element configured to visibly highlight areas of the region and registered to the imager to produce alignment of imaged features with highlighted features at the same location on the region, and at least one of a controller executing a program or logic configured to process acquired images from the imager to identify areas of the region determined not visible to the human eye, and control the overlay element to visibly highlight those areas on the region.